1. Home
  2. VERA vs DAC Comparison

VERA vs DAC Comparison

Compare VERA & DAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERA
  • DAC
  • Stock Information
  • Founded
  • VERA 2016
  • DAC 1972
  • Country
  • VERA United States
  • DAC Greece
  • Employees
  • VERA N/A
  • DAC N/A
  • Industry
  • VERA Biotechnology: Pharmaceutical Preparations
  • DAC Marine Transportation
  • Sector
  • VERA Health Care
  • DAC Consumer Discretionary
  • Exchange
  • VERA Nasdaq
  • DAC Nasdaq
  • Market Cap
  • VERA 1.5B
  • DAC 1.7B
  • IPO Year
  • VERA 2021
  • DAC 2006
  • Fundamental
  • Price
  • VERA $28.61
  • DAC $93.44
  • Analyst Decision
  • VERA Buy
  • DAC Strong Buy
  • Analyst Count
  • VERA 9
  • DAC 1
  • Target Price
  • VERA $62.75
  • DAC $105.00
  • AVG Volume (30 Days)
  • VERA 1.6M
  • DAC 77.5K
  • Earning Date
  • VERA 11-05-2025
  • DAC 11-17-2025
  • Dividend Yield
  • VERA N/A
  • DAC 3.66%
  • EPS Growth
  • VERA N/A
  • DAC N/A
  • EPS
  • VERA N/A
  • DAC 25.05
  • Revenue
  • VERA N/A
  • DAC $1,034,370,000.00
  • Revenue This Year
  • VERA N/A
  • DAC N/A
  • Revenue Next Year
  • VERA N/A
  • DAC $0.40
  • P/E Ratio
  • VERA N/A
  • DAC $3.73
  • Revenue Growth
  • VERA N/A
  • DAC 2.90
  • 52 Week Low
  • VERA $18.53
  • DAC $65.40
  • 52 Week High
  • VERA $51.27
  • DAC $97.26
  • Technical
  • Relative Strength Index (RSI)
  • VERA 50.88
  • DAC 54.83
  • Support Level
  • VERA $27.55
  • DAC $94.09
  • Resistance Level
  • VERA $29.90
  • DAC $97.26
  • Average True Range (ATR)
  • VERA 2.02
  • DAC 2.12
  • MACD
  • VERA 0.06
  • DAC 0.01
  • Stochastic Oscillator
  • VERA 62.09
  • DAC 51.64

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

About DAC Danaos Corporation

Danaos Corp is an international owner of containerships. It provides international seaborne transportation services by operating vessels in the containership sector of the shipping industry. The company's customers include, HMM, MSC, Yang Ming, Hapag Lloyd, ZIM, Maersk, COSCO, OOCL, ONE, PIL, Sealead, Niledutch, Samudera, OSC, and Arkas. Geographically, the company operates in Australia-Asia, Europe, and America, with maximum revenue from the Australia-Asia region. It has two reporting segments Container vessels and Drybulk vessels segment. It generates the majority of its revenue from Container vessels.

Share on Social Networks: